2Muller T, Batza H J, Schltiter H, et al. Eradication of Aujeszky's disease in Germany [ J]. J Vet Med B Infect Dis Vet Public Health, 2003, 50(5) : 207-213.
3Kit S. Genetically engineered vaccines for control of Aujeszky's dis- ease (pseudorabies) [J]. Vaccine, 1990, 8(5) : 420-424.
4He Y, Qian P, Zhang K, et al. Construction and immune response characterization of a recombinant response characterization of a re- combinant pseudorabies virus co-expressing capsid precursor protein ( P1 ) and a muhiepitope peptide of foot and mouth disease virus in swine [J]. Virus genes, 2008, 36(2) : 393-400.
5Maresch C, Lange E, Teifke J P, et al. Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against pseudorabies virus infection [J]. Vet Microbiol, 2012, 161 (1-2) : 20-25.
6Wu R, Bai C Y, Sun J Z, et al. Emergence of virulent pseudorabies virus infection in Northern China [J]. J Vet Sei, 2013, 14(3) : 363 -365.
7An T Q, Peng J M, Tian Z J, et al. Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012 [J]. Emerg Infect Dis, 2013, 19(11): 1749-1755.
9Kong H, Zhang K, Liu Y, et al. Attenuated live vaccine (Bartha- K16 ) caused pseudorabies (Aujeszky's disease) in sheep [ J ]. Vet Res Commun, 2013, 37(4) : 329-332. H.
10enderson L M, Kat Z J B, Eriekson G A. In vivo and in vitro ge- netic recombination between conventional and gene-deleted vaccine strains of Pseudorabies virus [ J]. Am J Vet Res, 1990, 51 : 1656-1662.
